„Globalna kardiologia” – impresje ze Światowego Kongresu Kardiologicznego, Pekin 16–19.06.2010 Raport konferencyjny

##plugins.themes.bootstrap3.article.main##

Łukasz Figiel
Jarosław D. Kasprzak

Abstrakt

Brak

##plugins.themes.bootstrap3.article.details##

Jak cytować
Figiel, Łukasz, & Kasprzak , J. D. (2010). „Globalna kardiologia” – impresje ze Światowego Kongresu Kardiologicznego, Pekin 16–19.06.2010. Medycyna Faktów , 3(3(8), 86-90. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2580
Dział
Artykuły

Bibliografia

1. O’Donnell M.J., Xavier D., Liu L. et al.: Risk factors for ischemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet 2010; DOI: 10.1016/S0140-6736(10)60834-3.
2. Wiviott S.D., Braunwald E., McCabe C.H. et al.: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2007; 357: 2001-2015.
3. Wallentin L., Becker R.C., Budaj A. et al.: Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2009; 361: 1045-1057.
4. Committee on Secondhand Smoke Exposure and Acute Coronary Events; Institute of Medicine. Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence. Washington, DC: National Academies Press, 2009.
5. Wong N.D., Gransar H., Rana J.S.: Utility of multiple biomarker index in asymptomatic adults depends of atherosclerotic burden. World Congress of Cardiology; 2010 June 17, Bejing, China. Oral abstract 65.
6. Connolly S.J., Ezekowitz M.D., Yusuf S. et al.: The RE-LY Steering Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N. Engl. J. Med. 2009 Sep 17; 361 (12): 1139-1151.